STOCK TITAN

Glaukos CFO Alex R. Thurman sells 15,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Glaukos Corp. SVP and Chief Financial Officer Alex R. Thurman exercised options for 15,000 common shares at a $45.71 exercise price on November 18, 2026, then sold 15,000 shares at reported weighted-average prices from $232.65 to $246.12 per share in 13 transactions. The option exercise and sales were made under a Rule 10b5-1 trading plan adopted August 18, 2026; the options expire March 15, 2027. The reported option position following the exercise was zero.

Insider Thurman Alex R.
Role SVP & CHIEF FINANCIAL OFFICER
Sold 15,000 shs ($3.55M)
Approx. gross sale proceeds $3.55M
Approx. exercise cost $686K
Approx. pre-tax spread $2.87M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F16, F17 15,000 $0.00 $0.00
Exercise Common Stock F1 15,000 $45.71 $686K
Sale Common Stock F2, F3, F1 3,209 $232.65 $747K
Sale Common Stock F2, F4, F1 1,493 $233.62 $349K
Sale Common Stock F2, F5, F1 2,330 $234.78 $547K
Sale Common Stock F2, F6, F1 548 $235.50 $129K
Sale Common Stock F2, F7, F1 2,021 $237.43 $480K
Sale Common Stock F2, F8, F1 1,190 $238.26 $284K
Sale Common Stock F2, F9, F1 826 $239.52 $198K
Sale Common Stock F2, F10 1,123 $240.24 $270K
Sale Common Stock F2, F11, F1 132 $241.49 $32K
Sale Common Stock F2, F12, F1 368 $242.67 $89K
Sale Common Stock F2, F13, F1 998 $243.91 $243K
Sale Common Stock F2, F14, F1 494 $244.40 $121K
Sale Common Stock F2, F15, F1 268 $246.12 $66K
Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Common Stock — 43,906 shares (Direct)
Footnotes (17)
  1. F1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person.
  2. F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
  3. F3. This transaction was executed in multiple trades at prices ranging from $232.18 to $233.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. F4. This transaction was executed in multiple trades at prices ranging from $233.21 to $234.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. F5. This transaction was executed in multiple trades at prices ranging from $234.22 to $235.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. F6. This transaction was executed in multiple trades at prices ranging from $235.28 to $235.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. F7. This transaction was executed in multiple trades at prices ranging from $236.89 to $237.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. F8. This transaction was executed in multiple trades at prices ranging from $237.92 to $238.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. F9. This transaction was executed in multiple trades at prices ranging from $238.95 to $239.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. F10. This transaction was executed in multiple trades at prices ranging from $239.96 to $240.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. F11. This transaction was executed in multiple trades at prices ranging from $241.00 to $241.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. F12. This transaction was executed in multiple trades at prices ranging from $242.01 to $243.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. F13. This transaction was executed in multiple trades at prices ranging from $243.28 to $244.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. F14. This transaction was executed in multiple trades at prices ranging from $244.30 to $245.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  15. F15. This transaction was executed in multiple trades at prices ranging from $245.51 to $246.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  16. F16. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
  17. F17. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years
Options exercised 15,000 options Exercise on November 18, 2026, for 15,000 common shares.
Common shares sold 15,000 shares Across 13 reported transactions on November 18, 2026.
Exercise price $45.71 per share Price for the option exercise on November 18, 2026.
Reported weighted-average sale prices $232.65–$246.12 per share Prices across the 13 reported sale transactions on November 18, 2026.
Options following exercise 0 options Reported option position after the November 18, 2026 exercise.
Rule 10b5-1 trading plan regulatory
"sales and option exercises were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported above reflects the weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
restricted stock units financial
"Includes 5,230 restricted stock units that have not yet vested or been delivered"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many GKOS shares did Alex R. Thurman sell?

He sold 15,000 shares in 13 reported transactions on November 18, 2026, at transaction-level weighted-average prices from $232.65 to $246.12 per share.

What were the terms of Alex R. Thurman's GKOS option exercise?

He exercised options for 15,000 shares at a $45.71 exercise price on November 18, 2026; the options expire March 15, 2027.

Were Alex R. Thurman's GKOS sales made under a trading plan?

Yes. The sales were made under a Rule 10b5-1 trading plan adopted August 18, 2026; the option exercise was also reported under that plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thurman Alex R.

(Last)(First)(Middle)
C/O GLAUKOS CORPORATION
ONE GLAUKOS WAY

(Street)
ALISO VIEJO CALIFORNIA 92656

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
GLAUKOS Corp [ GKOS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP & CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/18/2026M15,000A$45.7158,906(1)D
Common Stock11/18/2026S(2)3,209D$232.65(3)55,697(1)D
Common Stock11/18/2026S(2)1,493D$233.62(4)54,204(1)D
Common Stock11/18/2026S(2)2,330D$234.78(5)51,874(1)D
Common Stock11/18/2026S(2)548D$235.5(6)51,326(1)D
Common Stock11/18/2026S(2)2,021D$237.43(7)49,305(1)D
Common Stock11/18/2026S(2)1,190D$238.26(8)48,115(1)D
Common Stock11/18/2026S(2)826D$239.52(9)47,289(1)D
Common Stock11/18/2026S(2)1,123D$240.24(10)46,166(2)D
Common Stock11/18/2026S(2)132D$241.49(11)46,034(1)D
Common Stock11/18/2026S(2)368D$242.67(12)45,666(1)D
Common Stock11/18/2026S(2)998D$243.91(13)44,668(1)D
Common Stock11/18/2026S(2)494D$244.4(14)44,174(1)D
Common Stock11/18/2026S(2)268D$246.12(15)43,906(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$45.7111/18/2026M15,000(16) (17)03/15/2027Common Stock15,000$00D
Explanation of Responses:
1. Includes 5,230 restricted stock units that have not yet vested or been delivered to the Reporting Person.
2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
3. This transaction was executed in multiple trades at prices ranging from $232.18 to $233.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
4. This transaction was executed in multiple trades at prices ranging from $233.21 to $234.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5. This transaction was executed in multiple trades at prices ranging from $234.22 to $235.20. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
6. This transaction was executed in multiple trades at prices ranging from $235.28 to $235.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
7. This transaction was executed in multiple trades at prices ranging from $236.89 to $237.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
8. This transaction was executed in multiple trades at prices ranging from $237.92 to $238.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
9. This transaction was executed in multiple trades at prices ranging from $238.95 to $239.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
10. This transaction was executed in multiple trades at prices ranging from $239.96 to $240.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
11. This transaction was executed in multiple trades at prices ranging from $241.00 to $241.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
12. This transaction was executed in multiple trades at prices ranging from $242.01 to $243.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
13. This transaction was executed in multiple trades at prices ranging from $243.28 to $244.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
14. This transaction was executed in multiple trades at prices ranging from $244.30 to $245.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
15. This transaction was executed in multiple trades at prices ranging from $245.51 to $246.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
16. The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2026 with respect to options that expire on March 15, 2027.
17. These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years
Diana Scherer, Attorney-in-Fact11/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading